| Literature DB >> 31531383 |
Andrea N Burnett-Hartman1,2, Aruna Kamineni3, Douglas A Corley4, Amit G Singal5, Ethan A Halm5,6, Carolyn M Rutter7, Jessica Chubak3, Jeffrey K Lee4, Chyke A Doubeni8,9, John M Inadomi10, V Paul Doria-Rose11, Yingye Zheng2.
Abstract
BACKGROUND: Despite the importance of characterizing colonoscopy indication for quality monitoring and cancer screening program evaluation, there is no standard approach to documenting colonoscopy indication in medical records.Entities:
Keywords: Algorithm; Colonoscopy; Colorectal Cancer Screening; Electronic Health Records; Indication
Year: 2019 PMID: 31531383 PMCID: PMC6676916 DOI: 10.5334/egems.296
Source DB: PubMed Journal: EGEMS (Wash DC) ISSN: 2327-9214
Study population characteristics, by PROSPR Research Center.
| KPWA N = 600 N (%) | KPNC/SC N = 600 N (%) | Parkland-UTSW N = 596 N (%) | |
|---|---|---|---|
| 50–59 | 231 (38%) | 261 (44%) | 393 (66%) |
| 60–75 | 309 (52%) | 284 (47%) | 203 (34%) |
| 76–89 | 60 (10%) | 55 (9%) | 0 (0%) |
| Female | 332 (55%) | 322 (54%) | 396 (66%) |
| Male | 268 (45%) | 278 (46%) | 200 (34%) |
| Non-Hispanic White | 474 (79%) | 315 (53%) | 103 (17%) |
| Non-Hispanic Black | 25 (4%) | 44 (7%) | 187 (31%) |
| Hispanic | 28 (5%) | 125 (21%) | 252 (42%) |
| Asian/Pacific Islander | 33 (6%) | 96 (16%) | 47 (8%) |
| Other | 40 (7%) | 20 (3%) | 7 (1%) |
| 0 | 324 (54%) | 262 (44%) | 156 (26%) |
| 1–2 | 158 (26%) | 166 (27%) | 138 (23%) |
| 3+ | 78 (14%) | 105 (17%) | 41 (7%) |
| Missinga | 40 (7%) | 67 (11%) | 261 (44%) |
a Comorbidity index was calculated based on comorbidity status during the calendar year of the index colonoscopy. If data are unavailable for any month during the year, then comorbidity index was set to missing.
Abstracted indications, signs, and symptoms at colonoscopy exam, by PROSPR Research Center and source of indication data.
| KPWA N = 600 N (%) | KPNC/SC N = 600 N (%) | Parkland-UTSW N = 596 N (%) | |
|---|---|---|---|
| Diagnostic | 232 (39%) | 303 (51%) | 312 (52%) |
| Screening | 209 (35%) | 190 (32%) | 246 (41%) |
| Surveillance | 132 (22%) | 106 (18%) | 38 (6%) |
| Missing | 23 (4%) | ||
| Diagnostic | 197 (33%) | 257 (43%) | 247 (41%) |
| Screening | 248 (41%) | 235 (39%) | 309 (52%) |
| Surveillance | 94 (16%) | 77 (13%) | 39 (7%) |
| Missing | 58 (10%) | 31 (5%) | 1 (<1%) |
| Diagnostic | 159 (27%) | 230 (38%) | 234 (39%) |
| Screening | 262 (44%) | 237 (40%) | 313 (52%) |
| Surveillance | 135 (23%) | 129 (22%) | 48 (8%) |
| Missing | 43 (7%) | 2 (<1%) | 1 (<1%) |
| Positive FIT/FOBT | 63 (11%) | 131 (22%) | 76 (13%) |
| Abnormal sigmoidoscopy, barium enema, or imaging exam | 10 (2%) | 22 (4%) | 18 (3%) |
| Rectal bleeding | 63 (11%) | 96 (16%) | 105 (18%) |
| Other GI bleeding | 9 (2%) | 14 (2%) | 22 (4%) |
| Iron-deficiency anemia | 35 (6%) | 59 (10%) | 39 (7%) |
| Anemia, other or unspecified | 18 (3%) | 28 (5%) | 33 (6%) |
| Diarrhea, loose or watery stools | 48 (8%) | 28 (5%) | 30 (5%) |
| Constipation | 28 (5%) | 17 (3%) | 84 (14%) |
| Change in bowel habits | 30 (5%) | 8 (1%) | 21 (4%) |
| Irritable Bowel Syndrome (IBS) | 2 (<1%) | 6 (1%) | 3 (<1%) |
| Abdominal mass | 1 (<1%) | 0 (0%) | 2 (<1%) |
| Abdominal pain | 59 (10%) | 41 (7%) | 110 (18%) |
| Rectal pain | 2 (<1%) | 3 (<1%) | 9 (2%) |
| weight loss | 9 (2%) | 7 (1%) | 13 (2%) |
| Suspected new colorectal cancer | 0 (0%) | 0 (0%) | 2 (0.34%) |
| Inflammatory Bowel Disease (IBD) | 16 (3%) | 9 (2%) | 10 (2%) |
| Colitis other than IBD | 7 (1%) | 2 (<1%) | 4 (<1%) |
a Sources include: referral, clinic notes from the visit that prompted the referral, procedure report, pre-procedure notes, electronic data capture for laboratory-confirmed positive FIT/guaiac FOBT or iron-deficiency anemia.
b Sources include: referral or clinic notes from the visit that prompted the referral.
c Sources include: procedure report or pre-procedure notes.
d Signs and symptoms abstracted from any of the following sources: referral, clinic notes from the visit that prompted the referral, procedure report, or pre-procedure notes, or identified through electronic data capture for laboratory-confirmed positive FIT/FOBT or iron-deficiency anemia. Signs and symptoms are not mutually exclusive.
Comparisons of the overall performance, sensitivity, and specificity of the SEARCH and KPNC algorithms for classifying screening colonoscopy exams, by PROPSR Research Center.
| SEARCH Algorithm | KPNC Algorithm | |||
|---|---|---|---|---|
| AUCa | Specificity (95% CI)b | Sensitivity (95% CI) | Specificity (95% CI) | |
| 0.84 (0.80, 0.87) | 0.76 (0.69, 0.81) | 0.79 (0.73, 0.84) | 0.91 (0.88, 0.94) | |
| 0.76 (0.71, 0.80) | 0.60 (0.53, 0.68) | 0.78 (0.73, 0.84) | 0.89 (0.85, 0.92) | |
| 0.79 (0.75, 0.82) | 0.66 (0.60, 0.72) | 0.82 (0.77, 0.87) | 0.78 (0.74, 0.83) | |
a Area Under the Curve (AUC) measures the overall performance of the SEARCH indication algorithm for classifying screening colonoscopy exams.
b Sensitivity for the SEARCH algorithm was fixed at the sensitivity estimate from the KPNC indication algorithm and the corresponding specificity estimate for the SEARCH algorithm was reported.
Sources include: referral, clinic notes from the visit that prompted the referral, procedure report, pre-procedure notes, electronic data capture for laboratory-confirmed positive FIT/FOBT or iron-deficiency anemia.
Figure 1ROC curves and point-estimates for the performance of the SEARCH and KPNC algorithms for detecting screening colonoscopies in each CRC Research Center.
Sensitivity and specificity of the KPNC algorithm for classifying diagnostic and surveillance colonoscopy exams, by PROPSR Research Center.
| Diagnostic | Surveillance | |||
|---|---|---|---|---|
| Sensitivity (95% CI) | Specificity (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | |
| 0.89 (0.85, 0.93) | 0.82 (0.78, 0.86) | 0.67 (0.59, 0.75) | 0.96 (0.94, 0.98) | |
| 0.83 (0.79, 0.87) | 0.78 (0.74, 0.83) | 0.59 (0.50, 0.69) | 0.95 (0.93, 0.97) | |
| 0.78 (0.73, 0.82) | 0.74 (0.69, 0.79) | 0.11 (0.01, 0.20) | 1.00 (1.00, 1.00) | |
Sources include: referral, clinic notes from the visit that prompted the referral, procedure report, pre-procedure notes, electronic data capture for laboratory-confirmed positive FIT/FOBT or iron-deficiency anemia.